Device Thrombogenicty Emulator (DTE) – Design optimization Methodology for Cardiovascular Devices: A Study in Two Bileaflet MHV Designs

Patients who receive prosthetic heart valve (PHV) implants require mandatory anticoagulation medication after implantation due to the thrombogenic potential of the valve. Optimization of PHV designs may facilitate reduction of flow-induced thrombogenicity and reduce or eliminate the need for post-im...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Xenos, Michalis, Girdhar, Gaurav, Alemu, Yared, Jesty, Jolyon, Slepian, Marvin, Einav, Shmuel, Bluestein, Danny
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922449/
https://ncbi.nlm.nih.gov/pubmed/20483411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiomech.2010.04.020
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky